Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Lab-grown functional human liver cells to aid treatment
Researchers have developed a new approach to rapidly expand the number of human liver cells in the laboratory without losing their unique metabolic function.
- Read more about New gene map shows cancer's weak link
Scientists have mapped out the genes that keep our cells alive, thereby revealing which genes are crucial in diseases like cancer.
- Read more about Government moves on organ transplant facilities
Union Health Minister J.P. Nadda on Friday said the government has taken some decisive initiatives to accelerate the number of organ donations and to open organ transplant facilities at all major government hospitals.

[adsense:336x280:8701650588]
- Read more about High-potency cannabis kills white matter in brain
Smoking high-potency cannabis can damage a crucial part of the brain responsible for communication between the two brain hemispheres, researchers warn.
- Read more about FDA approves Portrazza to treat advanced squamous non-small cell lung cancer
The U.S. Food and Drug Administration approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) who have not previously received medication specifically for treating their advanced lung cancer. Portrazza is marketed by Eli Lilly and Company, based in Indianapolis, Indiana.
- Read more about FDA approves first seasonal influenza vaccine containing an adjuvant
The U.S. Food and Drug Administration approved Fluad, the first seasonal influenza vaccine containing an adjuvant. Fluad, a trivalent vaccine produced from three influenza virus strains (two subtype A and one type B), is approved for the prevention of seasonal influenza in people 65 years of age and older.
- Read more about Elocta, a new drug co-marketed by Sobi and Biogen, has been approved in the European Union for treatment of Haemophilia A
The injectable drug has been hailed as the first meaningful advance in treating haemophilia A in 20 years, and looks set to be a big earner for the partners. Elocta – a recombinant factor VIII Fc fusion protein (rFVIIIFc) – is already launched in the US, Canada and Australia under the Eloctate trade name, and is forecast to reach peak sales of $1.5 billion thanks to patient-friendly dosing that increases the time between injections.
27 November 2015

Daiichi Sankyo, Japan Vaccine & Sanofi to introduce Squarekids subcutaneous injection syringe, a 4-tetravalent combination vaccine

Daiichi Sankyo Co., Ltd., Japan Vaccine Co., Ltd. and Sanofi K.K. announced that they will launch "Squarekids subcutaneous injection syringe", a 4-tetravalent combination vaccine (DPT-IPV) for the prevention of diphtheria, pertussis, tetanus and poliomyelitis (polio) on December 9, 2015.
- Read more about Cocoa, green tea can help combat diabetes: study
Cocoa and green tea contain substances that can help prevent and treat renal complications or diabetic retinopathy, a study has shown.
- Read more about HIV infection surged to record numbers in Europe in 2014: WHO
A record number of people -- over 142,000 -- were diagnosed with HIV in Europe in 2014, the World Health Organisation (WHO) announced on Thursday.